Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Learning from past treatments and their outcome improves prediction of in vivo response to anti-HIV therapy.

Statistical applications in genetics and molecular biology - 1 Jan 2011

Saigo Hiroto, Altmann Andre, Bogojeska Jasmina, Müller Fabian, Nowozin Sebastian, Lengauer Thomas

Abstract excerpt

Infections with the human immunodeficiency virus type 1 (HIV-1) are treated with combinations of drugs. Unfortunately, HIV responds to the treatment by developing resistance mutations. Consequently, the genome of the viral target proteins is sequenced and inspected for resistance mutations as par...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Artificial Intelligence
Share to Computer Simulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Data Interpretation, Statistical

Share to Data Mining

Share to Databases, Factual

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Source

Identifiers

PMID: 21291416
DOI: 10.2202/1544-6115.1604

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21291416-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Learning from past treatments and their outcome improves prediction of in vivo response to anti-HIV therapy.PMID 21291416Read ↗

Mining complex genotypic features for predicting HIV-1 drug resistance.Semantic proximity Read ↗

Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1.Semantic proximity Read ↗

Dealing with sparse data in predicting outcomes of HIV combination therapies.Semantic proximity Read ↗

Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy.Semantic proximity Read ↗

Selecting anti-HIV therapies based on a variety of genomic and clinical factors.Semantic proximity Read ↗

Predicting HIV drug resistance using weighted machine learning method at target protein sequence-level.Semantic proximity Read ↗

Computational models for prediction of response to antiretroviral therapies.Semantic proximity Read ↗

Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.Semantic proximity Read ↗

Identification of Clinically Relevant HIV Vif Protein Motif Mutations through Machine Learning and Undersampling.Semantic proximity Read ↗

Predicting response to antiretroviral treatment by machine learning: the EuResist project.Semantic proximity Read ↗

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.Semantic proximity Read ↗

Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.